227 related articles for article (PubMed ID: 3528291)
1. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
Schäfer H; Mathey D; Hugo F; Bhakdi S
J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of the terminal C5b-9 complement complexes associated to S-protein and macrophage immunoreactive deposits in human damaged myocardial areas.
Vlaicu R; Rus HG; Niculescu F
Med Interne; 1988; 26(1):21-7. PubMed ID: 3399815
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
[TBL] [Abstract][Full Text] [Related]
7. Regulation of complement membrane attack complex formation in myocardial infarction.
Väkevä A; Laurila P; Meri S
Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345
[TBL] [Abstract][Full Text] [Related]
8. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.
Gerl VB; Bohl J; Pitz S; Stoffelns B; Pfeiffer N; Bhakdi S
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1104-8. PubMed ID: 11923252
[TBL] [Abstract][Full Text] [Related]
9. C5b-9 deposition in children with glomerular diseases.
Nanulescu M; Rus HG; Niculescu F; Cristea A; Florescu P
Med Interne; 1987; 25(2):99-104. PubMed ID: 3303285
[TBL] [Abstract][Full Text] [Related]
10. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction.
Väkevä A; Laurila P; Meri S
Immunology; 1993 Oct; 80(2):177-82. PubMed ID: 8262547
[TBL] [Abstract][Full Text] [Related]
11. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
Stewart JL; Kolb WP; Sodetz JM
J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
[TBL] [Abstract][Full Text] [Related]
12. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass.
Salama A; Hugo F; Heinrich D; Höge R; Müller R; Kiefel V; Mueller-Eckhardt C; Bhakdi S
N Engl J Med; 1988 Feb; 318(7):408-14. PubMed ID: 3340119
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies.
Kemp PA; Spragg JH; Brown JC; Morgan BP; Gunn CA; Taylor PW
J Clin Lab Immunol; 1992; 37(4):147-62. PubMed ID: 1285067
[TBL] [Abstract][Full Text] [Related]
14. Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes.
Xia P; Jordon RE; Geoghegan WD
J Clin Invest; 1988 Dec; 82(6):1939-47. PubMed ID: 2461964
[TBL] [Abstract][Full Text] [Related]
15. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE
Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593
[TBL] [Abstract][Full Text] [Related]
16. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium.
Joiner KA; Tartanian AB; Hammer CH; Schweinle JE
J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in human lymphoid germinal centres.
Zwirner J; Felber E; Schmidt P; Riethmüller G; Feucht HE
Immunology; 1989 Feb; 66(2):270-7. PubMed ID: 2925226
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
19. Complement localization in ischemic baboon myocardium.
McManus LM; Kolb WP; Crawford MH; O'Rourke RA; Grover FL; Pinckard RN
Lab Invest; 1983 Apr; 48(4):436-47. PubMed ID: 6339810
[TBL] [Abstract][Full Text] [Related]
20. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
